Ah well. There are still plenty of opportunities out there. Hope all our Aussie company do well and we can attract oversea funds/investors. Good luck to all.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%